Masimo Stock (NASDAQ: MASI) News, Forecasts and Analysis on Dec. 19, 2025: Investor Day Targets, Apple Verdict Tailwinds, and Why Shares Are Sliding
Masimo Corporation’s stock is ending the week under pressure, even as the medical-technology company has stacked up several headline catalysts across 2025—from a sweeping strategic reset and long-range financial targets to major legal developments in its long-running dispute with Apple.